Nagpur
+919405117673
+919405117673

Milrinone 10mg Injection Exporter in India | Cardiac Inotrope for ICU Use – Cordium Pharmaceuticals

Milrinone 10mg Injection is a potent phosphodiesterase-3 (PDE3) inhibitor used as a cardiac inotropic and vasodilator agent in critical care settings. It is widely administered in intensive care units for short-term management of severe congestive heart failure and acute cardiac decompensation. About Milrinone 10mg Injection Cordium Pharmaceuticals Pvt Ltd is a trusted global exporter of Milrinone 10mg Injection from India, supplying high-quality pharmaceutical products to hospitals, pharmacies, distributors, and healthcare institutions worldwide with strict quality compliance and reliable logistics support. We ensure fast and efficient delivery across major global markets including: United States, United Kingdom, Germany, France, Canada, Brazil, Russia, Mexico, Vietnam, Philippines, Nigeria, South Africa, Kenya, Tanzania, and Bangladesh. Therapeutic Uses: Acute decompensated heart failure Short-term IV support in cardiac surgery patients Severe congestive heart failure management in ICU settings Supportive therapy for low cardiac output states Dosage & Administration: Administered intravenously under strict medical supervision Loading dose may be followed by continuous infusion depending on clinical condition Dosage must be individualized based on patient response, renal function, and cardiac output (Use only under supervision of qualified healthcare professionals) Possible Side Effects: Ventricular arrhythmias Hypotension (low blood pressure) Headache or dizziness Thrombocytopenia Liver enzyme elevation (rare cases) Why Choose Cordium Pharmaceuticals Pvt Ltd: WHO-GMP certified manufacturing standards High-quality injectable formulations Reliable global export network Fast international shipping & documentation support Supply to hospitals, institutions, and authorized distributors only Contact for Global Orders: 📞 WhatsApp: +91-9405117673 📧 Email: info@cordiumpharma.com
 2026-04-20T07:12:31

Keywords